Mike Jones

Geçmiş katılımlar

• 2nd T-Cell Engager for Autoimmune Disease Summit

  27–29 Oct 2026Boston, United States of America

  • PanelPanel Discussion: Demonstrating Differentiation in a Crowded Autoimmune TCE Landscape While Navigating an Evolving Regulatory Pathwayİle: Patrick Baeuerle, Zhinan Xia, Yi Yang
• Oncology & Immunology Innovation Partnering & Licensing Summit

  9–10 Sept 2026Boston, United States of America

  • PanelPharma Icebreaker Panel Discussion: Investing into Immune Rest, Rebalance & Reconstitutionİle: David Blair, Nikhil Mutyal, Julie Di Paolo, Christopher Tan, Daniel Abernathy, Anna Rivkin, Saifur Rahman

Şu etkinlikteki diğer konuşmacılar: 2nd T-Cell Engager for Autoimmune Disease Summit

• Giovanni Abbadessa

  Chief Medical Officer, ModeX Therapeutics

• Xingfeng Bao

  Senior Vice President & Head of Research, GV20 Therapeutics LLC

• Alexander Boches

  Chief Business Officer, NovalGen

• Elaine Chen

  Senior Scientist, Translational Biology, Rondo Therapeutics

• David de Graaf

  Co-Founder, CEO & President, Reverb Therapeutics Inc.

• Mauricio Garcia-Atance

  Program Director, Hanson Wade

Etkinlik sayfasında 18 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: Oncology & Immunology Innovation Partnering & Licensing Summit

• Carla Bauer

  Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co

• Akihiro Furukawa

  Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo

• Adam Gilbert

  Science Partner, Flagship Pioneering

• Jason Kantor

  Chief Business Officer, Nurix Therapeutics, Inc.

• Giovanni Spagnolli

  Co-Founder & Chief Technology Officer, Sibylla Biotech srl

• Dori Thomas-Karyat

  Chief Executive Officer, Synthis Therapeutics

Etkinlik sayfasında 51 konuşmacının tümünü gör